Publication | Closed Access
Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients
18
Citations
11
References
2023
Year
Tofacitinib appears to be highly effective in targeting cutaneous manifestations in classic DM and ADM; however, minimal benefit in muscle strength in the DM or PM phenotype were observed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1